Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome
The hCHK2 gene encodes the human homolog of the yeast Cds1 and Rad53 G$_2$ checkpoint kinases, whose activation in response to DNA damage prevents cellular entry into mitosis. Here, it is shown that heterozygous germ line mutations in hCHK2 occur in Li-Fraumeni syndrome, a highly penetrant familial...
Saved in:
Published in: | Science (American Association for the Advancement of Science) 1999-12, Vol.286 (5449), p.2528-2531 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Article |
Language: | eng |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The hCHK2 gene encodes the human homolog of the yeast Cds1 and Rad53 G$_2$ checkpoint kinases, whose activation in response to DNA damage prevents cellular entry into mitosis. Here, it is shown that heterozygous germ line mutations in hCHK2 occur in Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in the TP53 gene. These observations suggest that hCHK2 is a tumor suppressor gene conferring predisposition to sarcoma, breast cancer, and brain tumors, and they also provide a link between the central role of p53 inactivation in human cancer and the well-defined G$_2$ checkpoint in yeast. |
---|---|
ISSN: | 0036-8075 1095-9203 |